Lipoxen Says Baxter International, Inc. Buys 4.8% Stake in Company

Bookmark and Share

Reuters -- British drug developer Lipoxen Plc said it raised 2.9 million pounds in a discounted share issue, in which Baxter International Inc bought a 4.8 percent stake in the company.

MORE ON THIS TOPIC